A guide to the interpretation of CSF indices

Laboratory Medicine

Volumn 36, Issue 9, 2005, Pages 558-562

  Ziadie, Mandolin ^a   Wians Jr , Frank H ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; IMMUNOGLOBULIN G; MYELIN PROTEIN; OLIGOCLONAL BAND;

AUTOIMMUNITY; CEREBROSPINAL FLUID EXAMINATION; ELECTROPHORESIS; HUMAN; IMMUNOBLOTTING; IMMUNOGLOBULIN PRODUCTION; LABORATORY TEST; MULTIPLE SCLEROSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; QUANTITATIVE ASSAY; REVIEW;

EID: 24144503328     PISSN: 00075027     EISSN: None     Source Type: Journal    
DOI: 10.1309/0D1FGL7AJXE3VQBY     Document Type: Review

References (17)

1. Noonan CW, Kathman SJ, White MC. Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurol. 2002;58:136-138.
2. th ed. Philadelphia: Elsevier, 2005:1382-1385.
3. Ferri FF, ed. Ferri's best test, a practical guide to clinical laboratory medicine and diagnostic imaging. Philadelphia: Elsevier; 2004:253.
4. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50:121-7
5. Fishman RA. Cerebrospinal fluid in diseases of the nervous system. 2nd ed. Philadelphia: W.B. Saunders Company; 1992.
6. Hershey LA, Trotter JL. The use and abuse of the cerebrospinal fluid IgG profile in the adult: a practical evaluation. Ann Neurol. 1980;4:515-524.
7. Fortini AS, Sander EL, Weinshenker BG, et al. Cerebrospinal fluid oligoclonal bands in the diagnosis of multiple sclerosis. Am J Clin Pathol. 2003;120:672-675.
8. Tourtellote WW, Staugaitis SM, Walsh MJ, et al. The basis of intra-blood-brain-barrier IgG synthesis. Ann Neurol. 17:21-27, 1985.
9. Olek MJ. Diagnosis, features, and prognosis of MS. En: Olek MJ, ed. Multiple sclerosis: etiology, diagnosis, and new treatment strategies. Totowa, NH: Humana Press; 2005:15-23.
10. Peter JB, Bowman RL, Boman Jr. RL, et al. Blood or plasma contamination of CSF: Effect on CNS IgG synthesis rate and IgG index [abstract]. Amer J Clin Pathol. 1987;87:422.
11. Blennow K, Fredman P, Wallin A, et al. Formulas for the quantitation of intrathecal IgG production: their validity in the presence of blood-brain barrier damage and their utility in multiple sclerosis. J Neurol Sci. 1994;121:90-96.
12. Tibbling G, Link H, Ohman S. Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest. 1977;37:385-390.
13. Peter J, Bowman RL. Intra-blood-brain barrier synthesis of IgG: comparison of IgG synthesis formulas in a computer model and in 1,629 consecutive specimens. Neurol. 1992;42:510-515.
14. Reiber H, Felgenhauer K. Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chim Acta. 1987;163:319-328.
15. Syndulko K, Tourtellotte WW, Conrad AJ, et al. Multiple Sclerosis Study Group, Alpha Interferon Study Group, Azathioprine Study Group. Transblood-brain-barrier albumin leakage and comparisons of intrathecal IgG synthesis calculations in multiple sclerosis patients. J Neurimmunol. 1993;46:185-192.
16. Wians FH Jr, Baskin LB. Electrophoretic methods for the evaluation of proteins in human body fluids. Diag Endo Metab. 1998;16:371-383.
17. Souverign JHM, Smith WG, Peet R, et al. Intrathecal IgG synthesis: Its detection by isoelectric focusing and IgG index. J Neurol Sci. 1989;93:211-220.